Fülöp-szigetek - angol - FDA (Food And Drug Administration)

ambica international corp.; distributor: the cathay yss distributors co., ltd. - isophane insulin human, recombinant dna - suspension for injection (sc) - 100iu/ml

Fülöp-szigetek - angol - FDA (Food And Drug Administration)

ambica international corporation; distributor: ambicare pharmaceuticals inc. - isophane insulin human, recombinant dna - suspension for injection (sc) - 100 iu/ml

Jordánia - angol - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة مستودع الادوية العربي - the arab drug store p.s.c - human insulin isophane (rdna origin)100 iu/ml - (rdna origin)100 iu/ml

Egyesült Államok - angol - NLM (National Library of Medicine)

a-s medication solutions - insulin human (unii: 1y17cti5sr) (insulin human - unii:1y17cti5sr) - insulin human 100 [iu] in 1 ml - novolin n is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. novolin n is contraindicated: risk summary available data from published studies over decades have not established an association with human insulin use during pregnancy and major birth defects, miscarriage or adverse maternal or fetal outcomes (see data). there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy (see clinical considerations). animal reproduction studies were not performed. the estimated background risk of major birth defects is 6-10% in women with pre-gestational diabetes with a hba1c >7 and has been reported to be as high as 20-25% in women with a hba1c >10. the estimated background risk of miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. clinical considerations diseas

Egyesült Államok - angol - NLM (National Library of Medicine)

novo nordisk - insulin human (unii: 1y17cti5sr) (insulin human - unii:1y17cti5sr) - insulin human 100 [iu] in 1 ml - novolin n is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. novolin n is contraindicated: risk summary available data from published studies over decades have not established an association with human insulin use during pregnancy and major birth defects, miscarriage or adverse maternal or fetal outcomes (see data). there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy (see clinical considerations). animal reproduction studies were not performed. the estimated background risk of major birth defects is 6-10% in women with pre-gestational diabetes with a hba1c >7 and has been reported to be as high as 20-25% in women with a hba1c >10. the estimated background risk of miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. clinical considerations diseas

Málta - angol - Medicines Authority

eli lilly & co. limited - insulin human (rdna) - suspension for injection - insulin human (rdna) 100 iu - drugs used in diabetes

Málta - angol - Medicines Authority

bioton sa ul. staroscinska 5, 02-516, warsaw, poland - insulin human, isophane, rdna - suspension for injection - insulin human isophane (rdna) 100 iu/ml - drugs used in diabetes

Málta - angol - Medicines Authority

bioton sa ul. staroscinska 5, 02-516, warsaw, poland - insulin human, isophane, rdna - suspension for injection - insulin human isophane (rdna) 100 iu/ml - drugs used in diabetes

Málta - angol - Medicines Authority

bioton sa ul. staroscinska 5, 02-516, warsaw, poland - insulin human, isophane, rdna - suspension for injection - insulin human isophane (rdna) 100 iu/ml - drugs used in diabetes

Málta - angol - Medicines Authority

bioton sa ul. staroscinska 5, 02-516, warsaw, poland - insulin human, isophane, rdna - suspension for injection - insulin human isophane (rdna) 100 iu/ml - drugs used in diabetes